首页 > 市场调查报告书 > 汽车工业

运输/物流

市场调查报告书

商品编码

1748588

2025-2029年全球生物製药市场

Global Bio-pharma Market 2025-2029

出版日期: 2025年06月07日 | 出版商:

TechNavio | 英文 229 Pages | 订单完成后即时交付

价格

简介目录图表

预计 2024 年至 2029 年期间生物製药市场将成长 3,118 亿美元，预测期内复合年增长率为 9%。

本报告对生物製药市场、市场规模和预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析进行了全面分析。

它提供了对当前市场情景、最新趋势和驱动因素以及整体市场环境的最新分析。市场受到健康障碍盛行率上升、老年人口成长以及生物製剂的标靶治疗机制的驱动。

市场覆盖
基准年	2025
年底	2029
预测期	2025-2029
成长动力	加速度
与前一年同期比较	8%
复合年增长率	9%
增量金额	3118亿美元

这项研究客观地结合了一手和二手讯息，并参考了行业主要参与者的意见。报告包含全面的市场规模数据、区域細項分析、供应商格局以及对主要企业的分析。报告同时包含历史数据和预测数据。

研究指出，疫苗产量的增加是未来几年推动生物製药市场成长的主要因素之一。此外，生命科学领域的投资增加以及市场参与者的收购增加将带来巨大的市场需求。

市场区隔
比较：按产品
单株抗体：2024 年至 2029 年市场规模及预测
重组生长因子：2024 年至 2029 年市场规模及预测
疫苗：2024-2029 年市场规模及预测
重组激素：2024 年至 2029 年市场规模及预测
其他：2024-2029 年市场规模及预测
按产品分類的市场机会

第九章按应用分類的市场细分

市场区隔
比较：按应用
肿瘤学：2024-2029 年市场规模及预测
自体免疫疾病：2024 年至 2029 年市场规模及预测
代谢紊乱：市场规模及预测（2024-2029）
荷尔蒙失调：2024-2029 年市场规模及预测
其他：2024-2029 年市场规模及预测
按应用分類的市场机会

第十章依药品类别细分市场

市场区隔
比较：按药物类别
专有生物製剂：2024 年至 2029 年市场规模及预测
生物相似药：2024-2029 年市场规模及预测
各药品类别的市场机会

第十一章客户情况

客户概览

第十二章地区情势

地理细分
区域比较
北美：2024-2029 年市场规模及预测
欧洲：2024-2029 年市场规模及预测
亚洲：2024-2029 年市场规模及预测
世界其他地区：2024-2029 年市场规模及预测
美国：市场规模及预测（2024-2029）
中国：2024-2029年市场规模及预测
德国：2024-2029年市场规模及预测
日本：2024-2029 年市场规模及预测
法国：2024-2029年市场规模及预测
巴西：2024-2029 年市场规模及预测
英国：2024-2029 年市场规模及预测
加拿大：2024-2029 年市场规模及预测
印度：2024-2029 年市场规模及预测
韩国：2024-2029 年市场规模及预测
按地区分類的市场机会

第十三章驱动因素、挑战、机会与限制因素

市场驱动因素
市场挑战
驱动因素和挑战的影响
市场机会与限制

第十四章竞争格局

概述
竞争格局
令人困惑的情况
产业风险

第十五章竞争分析

公司简介
企业排名指数
公司市场定位
AbbVie Inc.
Amgen Inc.
Astellas Pharma Inc.
AstraZeneca Plc
Bayer AG
Biogen Inc.
Bristol Myers Squibb Co.
Eli Lilly and Co.
F. Hoffmann La Roche Ltd.
Johnson and Johnson Services Inc.
Novartis AG
Novo Nordisk AS
Pfizer Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.

第十六章附录

简介目录图表

Product Code: IRTNTR77011

The bio-pharma market is forecasted to grow by USD 311.8 bn during 2024-2029, accelerating at a CAGR of 9% during the forecast period. The report on the bio-pharma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of health disorders, growing geriatric population, and targeted therapeutic mechanism of biologics.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	8%
CAGR	9%
Incremental Value	$311.8 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's bio-pharma market is segmented as below:

By Product

Monoclonal antibodies
Recombinant growth factors
Vaccines
Recombinant hormones
Others

By Application

Oncology
Autoimmune disorder
Metabolic disorder
Hormonal disorder
Others

By Drug Class

Proprietary biologics
Biosimilars

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rise in production of vaccines as one of the prime reasons driving the bio-pharma market growth during the next few years. Also, growing investments in life sciences sector and growing number of acquisitions by market companies will lead to sizable demand in the market.

The report on the bio-pharma market covers the following areas:

Bio-Pharma Market sizing
Bio-Pharma Market forecast
Bio-Pharma Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bio-pharma market vendors that include AbbVie Inc., Amgen Inc., Angelini S.p.a., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Ipsen Pharma, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Vertex Pharmaceuticals Inc.. Also, the bio-pharma market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Drug Class
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Bio-Pharma Market 2019 - 2023
- Historic Market Size - Data Table on Global Bio-Pharma Market 2019 - 2023 ($ billion)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ billion)
5.4 Drug Class segment analysis 2019 - 2023
- Historic Market Size - Drug Class Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 The impact of AI in the global bio-pharma market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Monoclonal antibodies - Market size and forecast 2024-2029
- Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
- Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
8.4 Recombinant growth factors - Market size and forecast 2024-2029
- Chart on Recombinant growth factors - Market size and forecast 2024-2029 ($ billion)
- Data Table on Recombinant growth factors - Market size and forecast 2024-2029 ($ billion)
- Chart on Recombinant growth factors - Year-over-year growth 2024-2029 (%)
- Data Table on Recombinant growth factors - Year-over-year growth 2024-2029 (%)
8.5 Vaccines - Market size and forecast 2024-2029
- Chart on Vaccines - Market size and forecast 2024-2029 ($ billion)
- Data Table on Vaccines - Market size and forecast 2024-2029 ($ billion)
- Chart on Vaccines - Year-over-year growth 2024-2029 (%)
- Data Table on Vaccines - Year-over-year growth 2024-2029 (%)
8.6 Recombinant hormones - Market size and forecast 2024-2029
- Chart on Recombinant hormones - Market size and forecast 2024-2029 ($ billion)
- Data Table on Recombinant hormones - Market size and forecast 2024-2029 ($ billion)
- Chart on Recombinant hormones - Year-over-year growth 2024-2029 (%)
- Data Table on Recombinant hormones - Year-over-year growth 2024-2029 (%)
8.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.8 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)

9 Market Segmentation by Application

9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
9.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
9.4 Autoimmune disorder - Market size and forecast 2024-2029
- Chart on Autoimmune disorder - Market size and forecast 2024-2029 ($ billion)
- Data Table on Autoimmune disorder - Market size and forecast 2024-2029 ($ billion)
- Chart on Autoimmune disorder - Year-over-year growth 2024-2029 (%)
- Data Table on Autoimmune disorder - Year-over-year growth 2024-2029 (%)
9.5 Metabolic disorder - Market size and forecast 2024-2029
- Chart on Metabolic disorder - Market size and forecast 2024-2029 ($ billion)
- Data Table on Metabolic disorder - Market size and forecast 2024-2029 ($ billion)
- Chart on Metabolic disorder - Year-over-year growth 2024-2029 (%)
- Data Table on Metabolic disorder - Year-over-year growth 2024-2029 (%)
9.6 Hormonal disorder - Market size and forecast 2024-2029
- Chart on Hormonal disorder - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hormonal disorder - Market size and forecast 2024-2029 ($ billion)
- Chart on Hormonal disorder - Year-over-year growth 2024-2029 (%)
- Data Table on Hormonal disorder - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Application
- Market opportunity by Application ($ billion)
- Data Table on Market opportunity by Application ($ billion)

10 Market Segmentation by Drug Class

10.1 Market segments
- Chart on Drug Class - Market share 2024-2029 (%)
- Data Table on Drug Class - Market share 2024-2029 (%)
10.2 Comparison by Drug Class
- Chart on Comparison by Drug Class
- Data Table on Comparison by Drug Class
10.3 Proprietary biologics - Market size and forecast 2024-2029
- Chart on Proprietary biologics - Market size and forecast 2024-2029 ($ billion)
- Data Table on Proprietary biologics - Market size and forecast 2024-2029 ($ billion)
- Chart on Proprietary biologics - Year-over-year growth 2024-2029 (%)
- Data Table on Proprietary biologics - Year-over-year growth 2024-2029 (%)
10.4 Biosimilars - Market size and forecast 2024-2029
- Chart on Biosimilars - Market size and forecast 2024-2029 ($ billion)
- Data Table on Biosimilars - Market size and forecast 2024-2029 ($ billion)
- Chart on Biosimilars - Year-over-year growth 2024-2029 (%)
- Data Table on Biosimilars - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Drug Class
- Market opportunity by Drug Class ($ billion)
- Data Table on Market opportunity by Drug Class ($ billion)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
15.6 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.7 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
15.8 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.9 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key offerings
- SWOT
15.10 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.11 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
15.12 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.13 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.15 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
15.16 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.17 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
15.18 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

简介目录图表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Bio-Pharma Market 2019 - 2023 ($ billion)
Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ billion)
Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ billion)
Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ billion)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Product - Market share 2024-2029 (%)
Exhibits39: Data Table on Product - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Product
Exhibits41: Data Table on Comparison by Product
Exhibits42: Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
Exhibits43: Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion)
Exhibits44: Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Recombinant growth factors - Market size and forecast 2024-2029 ($ billion)
Exhibits47: Data Table on Recombinant growth factors - Market size and forecast 2024-2029 ($ billion)
Exhibits48: Chart on Recombinant growth factors - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Recombinant growth factors - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Vaccines - Market size and forecast 2024-2029 ($ billion)
Exhibits51: Data Table on Vaccines - Market size and forecast 2024-2029 ($ billion)
Exhibits52: Chart on Vaccines - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Vaccines - Year-over-year growth 2024-2029 (%)
Exhibits54: Chart on Recombinant hormones - Market size and forecast 2024-2029 ($ billion)
Exhibits55: Data Table on Recombinant hormones - Market size and forecast 2024-2029 ($ billion)
Exhibits56: Chart on Recombinant hormones - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Recombinant hormones - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits62: Market opportunity by Product ($ billion)
Exhibits63: Data Table on Market opportunity by Product ($ billion)
Exhibits64: Chart on Application - Market share 2024-2029 (%)
Exhibits65: Data Table on Application - Market share 2024-2029 (%)
Exhibits66: Chart on Comparison by Application
Exhibits67: Data Table on Comparison by Application
Exhibits68: Chart on Oncology - Market size and forecast 2024-2029 ($ billion)
Exhibits69: Data Table on Oncology - Market size and forecast 2024-2029 ($ billion)
Exhibits70: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Autoimmune disorder - Market size and forecast 2024-2029 ($ billion)
Exhibits73: Data Table on Autoimmune disorder - Market size and forecast 2024-2029 ($ billion)
Exhibits74: Chart on Autoimmune disorder - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Autoimmune disorder - Year-over-year growth 2024-2029 (%)
Exhibits76: Chart on Metabolic disorder - Market size and forecast 2024-2029 ($ billion)
Exhibits77: Data Table on Metabolic disorder - Market size and forecast 2024-2029 ($ billion)
Exhibits78: Chart on Metabolic disorder - Year-over-year growth 2024-2029 (%)
Exhibits79: Data Table on Metabolic disorder - Year-over-year growth 2024-2029 (%)
Exhibits80: Chart on Hormonal disorder - Market size and forecast 2024-2029 ($ billion)
Exhibits81: Data Table on Hormonal disorder - Market size and forecast 2024-2029 ($ billion)
Exhibits82: Chart on Hormonal disorder - Year-over-year growth 2024-2029 (%)
Exhibits83: Data Table on Hormonal disorder - Year-over-year growth 2024-2029 (%)
Exhibits84: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits85: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits86: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits87: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits88: Market opportunity by Application ($ billion)
Exhibits89: Data Table on Market opportunity by Application ($ billion)
Exhibits90: Chart on Drug Class - Market share 2024-2029 (%)
Exhibits91: Data Table on Drug Class - Market share 2024-2029 (%)
Exhibits92: Chart on Comparison by Drug Class
Exhibits93: Data Table on Comparison by Drug Class
Exhibits94: Chart on Proprietary biologics - Market size and forecast 2024-2029 ($ billion)
Exhibits95: Data Table on Proprietary biologics - Market size and forecast 2024-2029 ($ billion)
Exhibits96: Chart on Proprietary biologics - Year-over-year growth 2024-2029 (%)
Exhibits97: Data Table on Proprietary biologics - Year-over-year growth 2024-2029 (%)
Exhibits98: Chart on Biosimilars - Market size and forecast 2024-2029 ($ billion)
Exhibits99: Data Table on Biosimilars - Market size and forecast 2024-2029 ($ billion)
Exhibits100: Chart on Biosimilars - Year-over-year growth 2024-2029 (%)
Exhibits101: Data Table on Biosimilars - Year-over-year growth 2024-2029 (%)
Exhibits102: Market opportunity by Drug Class ($ billion)
Exhibits103: Data Table on Market opportunity by Drug Class ($ billion)
Exhibits104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits105: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits107: Chart on Geographic comparison
Exhibits108: Data Table on Geographic comparison
Exhibits109: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits110: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits111: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits114: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits115: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits118: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits119: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits126: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits127: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits134: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits135: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits138: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits139: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits146: Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits147: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits150: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits151: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits154: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits155: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits157: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits158: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits159: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits160: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits161: Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits162: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits163: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits164: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits165: Market opportunity By Geographical Landscape ($ billion)
Exhibits166: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits167: Impact of drivers and challenges in 2024 and 2029
Exhibits168: Overview on criticality of inputs and factors of differentiation
Exhibits169: Overview on factors of disruption
Exhibits170: Impact of key risks on business
Exhibits171: Companies covered
Exhibits172: Company ranking index
Exhibits173: Matrix on companies position and classification
Exhibits174: AbbVie Inc. - Overview
Exhibits175: AbbVie Inc. - Product / Service
Exhibits176: AbbVie Inc. - Key news
Exhibits177: AbbVie Inc. - Key offerings
Exhibits178: SWOT
Exhibits179: Amgen Inc. - Overview
Exhibits180: Amgen Inc. - Product / Service
Exhibits181: Amgen Inc. - Key news
Exhibits182: Amgen Inc. - Key offerings
Exhibits183: SWOT
Exhibits184: Astellas Pharma Inc. - Overview
Exhibits185: Astellas Pharma Inc. - Product / Service
Exhibits186: Astellas Pharma Inc. - Key offerings
Exhibits187: SWOT
Exhibits188: AstraZeneca Plc - Overview
Exhibits189: AstraZeneca Plc - Product / Service
Exhibits190: AstraZeneca Plc - Key news
Exhibits191: AstraZeneca Plc - Key offerings
Exhibits192: SWOT
Exhibits193: Bayer AG - Overview
Exhibits194: Bayer AG - Business segments
Exhibits195: Bayer AG - Key news
Exhibits196: Bayer AG - Key offerings
Exhibits197: Bayer AG - Segment focus
Exhibits198: SWOT
Exhibits199: Biogen Inc. - Overview
Exhibits200: Biogen Inc. - Product / Service
Exhibits201: Biogen Inc. - Key offerings
Exhibits202: SWOT
Exhibits203: Bristol Myers Squibb Co. - Overview
Exhibits204: Bristol Myers Squibb Co. - Product / Service
Exhibits205: Bristol Myers Squibb Co. - Key news
Exhibits206: Bristol Myers Squibb Co. - Key offerings
Exhibits207: SWOT
Exhibits208: Eli Lilly and Co. - Overview
Exhibits209: Eli Lilly and Co. - Product / Service
Exhibits210: Eli Lilly and Co. - Key offerings
Exhibits211: SWOT
Exhibits212: F. Hoffmann La Roche Ltd. - Overview
Exhibits213: F. Hoffmann La Roche Ltd. - Business segments
Exhibits214: F. Hoffmann La Roche Ltd. - Key news
Exhibits215: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits216: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits217: SWOT
Exhibits218: Johnson and Johnson Services Inc. - Overview
Exhibits219: Johnson and Johnson Services Inc. - Business segments
Exhibits220: Johnson and Johnson Services Inc. - Key news
Exhibits221: Johnson and Johnson Services Inc. - Key offerings
Exhibits222: Johnson and Johnson Services Inc. - Segment focus
Exhibits223: SWOT
Exhibits224: Novartis AG - Overview
Exhibits225: Novartis AG - Business segments
Exhibits226: Novartis AG - Key news
Exhibits227: Novartis AG - Key offerings
Exhibits228: Novartis AG - Segment focus
Exhibits229: SWOT
Exhibits230: Novo Nordisk AS - Overview
Exhibits231: Novo Nordisk AS - Business segments
Exhibits232: Novo Nordisk AS - Key offerings
Exhibits233: Novo Nordisk AS - Segment focus
Exhibits234: SWOT
Exhibits235: Pfizer Inc. - Overview
Exhibits236: Pfizer Inc. - Product / Service
Exhibits237: Pfizer Inc. - Key news
Exhibits238: Pfizer Inc. - Key offerings
Exhibits239: SWOT
Exhibits240: Sanofi SA - Overview
Exhibits241: Sanofi SA - Business segments
Exhibits242: Sanofi SA - Key news
Exhibits243: Sanofi SA - Key offerings
Exhibits244: Sanofi SA - Segment focus
Exhibits245: SWOT
Exhibits246: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits247: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits248: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits249: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits250: SWOT
Exhibits251: Inclusions checklist
Exhibits252: Exclusions checklist
Exhibits253: Currency conversion rates for US$
Exhibits254: Research methodology
Exhibits255: Information sources
Exhibits256: Data validation
Exhibits257: Validation techniques employed for market sizing
Exhibits258: Data synthesis
Exhibits259: 360 degree market analysis
Exhibits260: List of abbreviations

02-2729-4219

+886-2-2729-4219

License/价格

2025-2029年全球生物製药市场

Global Bio-pharma Market 2025-2029

目录

第一章执行摘要

第二章 Technavio 分析

第三章市场状况

第四章市场规模

第五章市场规模表现

第六章定性分析

第七章五力分析

8.按产品细分市场